Showing 1 - 10 of 291
Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal Joint Committee (G-BA). In case no head-to-head studies are available for direct...
Persistent link: https://www.econbiz.de/10010526947
for Health and Care Excellence (NICE; England). Methods: The following aspects were examined: guidance texts on … approach taken by NICE seems to be more open and less restrictive as compared with G-BA/IQWiG. Any kind of potentially relevant …
Persistent link: https://www.econbiz.de/10010528485
Persistent link: https://www.econbiz.de/10000001457
significantly smaller in Germany, significantly larger in France, and does not differ significantly in the UK. The results for wages … services firms into exporting does not show up among firms from France and the UK where no statistically significant …
Persistent link: https://www.econbiz.de/10010286601
Persistent link: https://www.econbiz.de/10000556766
Persistent link: https://www.econbiz.de/10000587825
Persistent link: https://www.econbiz.de/10000415560
Persistent link: https://www.econbiz.de/10000416729
Persistent link: https://www.econbiz.de/10000417348